M
Marcelo U. Ferreira
Researcher at University of São Paulo
Publications - 306
Citations - 10840
Marcelo U. Ferreira is an academic researcher from University of São Paulo. The author has contributed to research in topics: Plasmodium vivax & Malaria. The author has an hindex of 55, co-authored 281 publications receiving 9447 citations. Previous affiliations of Marcelo U. Ferreira include Nagoya University & Faculdade de Medicina de São José do Rio Preto.
Papers
More filters
Journal ArticleDOI
Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum.
Tim J. Anderson,Bernhard Haubold,Jeff T. Williams,Jose G. Estrada-Franco,Lynne Richardson,Rene Mollinedo,Moses J. Bockarie,John L. Mokili,Sungano Mharakurwa,Neil French,James A. G. Whitworth,Iván D. Vélez,Alan Brockman,François Nosten,Marcelo U. Ferreira,Karen P. Day +15 more
TL;DR: The intraspecific patterns of diversity and genetic differentiation observed in P. falciparum are strikingly similar to those seen in interspecific comparisons of plants and animals with differing levels of outcrossing, suggesting that similar processes may be involved.
Journal ArticleDOI
Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms
TL;DR: The current laboratory diagnosis, epidemiology and main clinical features of both the systemic and ocular forms of human toxocariasis are reviewed to provide an updated overview of this neglected but highly prevalent human infection.
Journal ArticleDOI
Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax
Daniel Hupalo,Zunping Luo,Alexandre Melnikov,Patrick L. Sutton,Peter Rogov,Ananias A. Escalante,Andres F. Vallejo,Sócrates Herrera,Myriam Arévalo-Herrera,Qi Fan,Ying Wang,Liwang Cui,Carmen Lucas,Salomón Durand,Juan F. Sanchez,G. Christian Baldeviano,Andres G. Lescano,Moses Laman,Céline Barnadas,Céline Barnadas,Alyssa E. Barry,Alyssa E. Barry,Ivo Mueller,Ivo Mueller,James W. Kazura,Alex Eapen,Deena Kanagaraj,Neena Valecha,Marcelo U. Ferreira,Wanlapa Roobsoong,Wang Nguitragool,Jetsumon Sattabonkot,Dionicia Gamboa,Margaret Kosek,Joseph M. Vinetz,Joseph M. Vinetz,Lilia González-Cerón,Bruce W. Birren,Daniel E. Neafsey,Jane M. Carlton +39 more
TL;DR: Signals of natural selection suggest that P. vivax is evolving in response to antimalarial drugs and is adapting to regional differences in the human host and the mosquito vector, highlighting the variable epidemiology of this parasite species.
Journal ArticleDOI
Genomic analysis of local variation and recent evolution in Plasmodium vivax
Richard D. Pearson,Richard D. Pearson,Roberto Amato,Roberto Amato,Sarah Auburn,Olivo Miotto,Olivo Miotto,Olivo Miotto,Jacob Almagro-Garcia,Chanaki Amaratunga,Seila Suon,Sivanna Mao,Rintis Noviyanti,Hidayat Trimarsanto,Jutta Marfurt,Nicholas M. Anstey,Timothy William,Maciej F. Boni,Christiane Dolecek,Hien Tinh Tran,Nicholas J. White,Pascal Michon,Pascal Michon,Peter Siba,Livingstone Tavul,Gabrielle Harrison,Gabrielle Harrison,Alyssa E. Barry,Alyssa E. Barry,Ivo Mueller,Ivo Mueller,Marcelo U. Ferreira,Nadira D. Karunaweera,Milijaona Randrianarivelojosia,Qi Gao,Christina Hubbart,Lee Hart,Ben Jeffery,Eleanor Drury,Daniel Mead,Mihir Kekre,Susana Campino,Magnus Manske,Victoria Cornelius,Victoria Cornelius,Bronwyn MacInnis,Kirk A. Rockett,Kirk A. Rockett,Alistair Miles,Alistair Miles,Julian C. Rayner,Rick M. Fairhurst,François Nosten,François Nosten,Ric N. Price,Ric N. Price,Dominic P. Kwiatkowski,Dominic P. Kwiatkowski +57 more
TL;DR: A dynamic landscape of local evolutionary adaptation in the parasite population is demonstrated and will provide a foundation for genomic surveillance to guide effective strategies for control and elimination of P. vivax.
Journal ArticleDOI
Challenges for malaria elimination in Brazil
TL;DR: Challenges for malaria elimination addressed include the high prevalence of symptomless and submicroscopic infections, emerging anti-malarial drug resistance in P. falciparum and Plasmodium vivax and the lack of safe anti-relapse drugs, and the largely neglected burden of malaria in pregnancy.